BlackRock Health Sciences Trust
About this Fund
The BlackRock Health Sciences Trust is a premier mutual fund company that specializes in providing a diverse range of investment solutions to help individuals and institutions achieve their long-term financial goals through effective asset management and wealth management strategies. With a strong focus on the health sciences sector, the company offers a variety of mutual funds that cater to different investor preferences and risk tolerance levels, including equity, debt, and hybrid funds. For investors seeking to capitalize on the growth potential of the healthcare industry, the BlackRock Health Sciences Trust provides a compelling opportunity to create a well-diversified portfolio that can help mitigate risk and maximize returns through a systematic investment plan, or SIP. The company's investment approach is centered on thorough research and analysis, leveraging the expertise of its experienced team of portfolio managers who work tirelessly to identify high-quality investment opportunities that align with the company's rigorous investment criteria. By prioritizing the needs of its investors, the BlackRock Health Sciences Trust has established itself as a trusted partner in the asset management industry, committed to delivering exceptional investment results and outstanding client service. With its extensive resources and global reach, the company is well-positioned to navigate the complexities of the investment landscape, providing its clients with access to a broad range of investment products and strategies that can help them achieve their unique financial objectives. Whether investors are seeking to build wealth over the long term or generate income through regular dividend payments, the BlackRock Health Sciences Trust offers a comprehensive suite of mutual funds that can help them succeed, backed by a proven track record of investment excellence and a deep commitment to responsible investing practices. As a leading player in the mutual fund industry, the BlackRock Health Sciences Trust has earned the trust of investors worldwide, who appreciate the company's unwavering dedication to helping them achieve their financial goals through a combination of investment expertise, innovative solutions, and exceptional client support. By choosing the BlackRock Health Sciences Trust, investors can tap into the company's extensive knowledge and experience in the health sciences sector, gaining a competitive edge in the pursuit of their investment objectives and enjoying the benefits of a well-managed portfolio that is tailored to their individual needs and circumstances. Through its mutual funds, the company provides investors with a convenient and cost-effective way to gain exposure to a broad range of asset classes and investment strategies, making it an ideal choice for those seeking to simplify their investment process and achieve their long-term financial aspirations. With its strong investment capabilities, robust risk management framework, and unyielding commitment to investor satisfaction, the BlackRock Health Sciences Trust has established itself as a trusted and reliable partner for investors seeking to navigate the complexities of the investment landscape and achieve their financial goals through a well-diversified portfolio of mutual funds.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABT Abbott Laboratories Since 2026-05-10 | 002824100 | Equity (Common) |
4.00%
|
$22.73 | 181,376 |
| 2 | ABBV AbbVie Inc Since 2026-05-10 | 00287Y109 | Equity (Common) |
4.05%
|
$23.01 | 100,720 |
| 3 | A Agilent Technologies Inc Since 2026-05-10 | 00846U101 | Equity (Common) |
0.83%
|
$4.72 | 34,724 |
| 4 | AGIO Agios Pharmaceuticals Inc Since 2026-05-10 | 00847X104 | Equity (Common) |
0.14%
|
$0.82 | 30,245 |
| 5 | ALLO Allogene Therapeutics Inc Since 2026-05-10 | 019770106 | Equity (Common) |
0.03%
|
$0.14 | 105,465 |
| 6 | ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 | 02043Q107 | Equity (Common) |
1.66%
|
$9.44 | 23,741 |
| 7 | COR Cencora Inc Since 2026-05-10 | 03073E105 | Equity (Common) |
1.23%
|
$6.99 | 20,687 |
| 8 | AMGN Amgen Inc Since 2026-05-10 | 031162100 | Equity (Common) |
2.99%
|
$16.98 | 51,861 |
| 9 | APGE Apogee Therapeutics Inc Since 2026-05-10 | 03770N101 | Equity (Common) |
0.24%
|
$1.34 | 17,780 |
| 10 | ACLX Arcellx Inc Since 2026-05-10 | 03940C100 | Equity (Common) |
0.19%
|
$1.05 | 16,128 |
| 11 | RCUS Arcus Biosciences Inc Since 2026-05-10 | 03969F109 | Equity (Common) |
0.17%
|
$0.94 | 39,654 |
| 12 | BEAM Beam Therapeutics Inc Since 2026-05-10 | 07373V105 | Equity (Common) |
0.07%
|
$0.41 | 14,611 |
| 13 | BIO-B Bio-Rad Laboratories Inc Since 2026-05-10 | 090572207 | Equity (Common) |
0.12%
|
$0.66 | 2,181 |
| 14 | BMRN BioMarin Pharmaceutical Inc Since 2026-05-10 | 09061G101 | Equity (Common) |
0.31%
|
$1.76 | 29,577 |
| 15 | BIIB Biogen Inc Since 2026-05-10 | 09062X103 | Equity (Common) |
0.60%
|
$3.44 | 19,524 |
| 16 | AZN AstraZeneca PLC Since 2026-05-10 | — | Equity (Common) |
1.29%
|
$7.31 | 39,479 |
| 17 | BBOT BridgeBio Oncology Therapeutics Inc Since 2026-05-10 | 107924102 | Equity (Common) |
0.13%
|
$0.75 | 60,030 |
| 18 | BBIO Bridgebio Pharma Inc Since 2026-05-10 | 10806X102 | Equity (Common) |
0.24%
|
$1.38 | 18,055 |
| 19 | CGON CG oncology Inc Since 2026-05-10 | 156944100 | Equity (Common) |
0.04%
|
$0.21 | 5,095 |
| 20 | CRL Charles River Laboratories International Inc Since 2026-05-10 | 159864107 | Equity (Common) |
0.17%
|
$0.98 | 4,936 |
| 21 | COGT Cogent Biosciences Inc Since 2026-05-10 | 19240Q201 | Equity (Common) |
0.23%
|
$1.33 | 37,385 |
| 22 | DNLI Denali Therapeutics Inc Since 2026-05-10 | 24823R105 | Equity (Common) |
0.08%
|
$0.47 | 28,638 |
| 23 | DXCM Dexcom Inc Since 2026-05-10 | 252131107 | Equity (Common) |
0.68%
|
$3.84 | 57,910 |
| 24 | IRON Disc Medicine Inc Since 2026-05-10 | 254604101 | Equity (Common) |
0.11%
|
$0.60 | 7,529 |
| 25 | DYN Dyne Therapeutics Inc Since 2026-05-10 | 26818M108 | Equity (Common) |
0.08%
|
$0.47 | 23,908 |
| 26 | EWTX Edgewise Therapeutics Inc Since 2026-05-10 | 28036F105 | Equity (Common) |
0.10%
|
$0.55 | 22,279 |
| 27 | ENTA Enanta Pharmaceuticals Inc Since 2026-05-10 | 29251M106 | Equity (Common) |
0.12%
|
$0.67 | 42,512 |
| 28 | EXEL Exelixis Inc Since 2026-05-10 | 30161Q104 | Equity (Common) |
0.15%
|
$0.87 | 19,863 |
| 29 | EYPT EyePoint Inc Since 2026-05-10 | 30233G209 | Equity (Common) |
0.05%
|
$0.30 | 16,320 |
| 30 | FDMT 4D Molecular Therapeutics Inc Since 2026-05-10 | 35104E100 | Equity (Common) |
0.02%
|
$0.09 | 11,491 |
| 31 | GEHC GE HealthCare Technologies Inc Since 2026-05-10 | 36266G107 | Equity (Common) |
0.30%
|
$1.72 | 20,917 |
| 32 | GILD Gilead Sciences Inc Since 2026-05-10 | 375558103 | Equity (Common) |
3.25%
|
$18.47 | 150,487 |
| 33 | GOSS Gossamer Bio Inc Since 2026-05-10 | 38341P102 | Equity (Common) |
0.02%
|
$0.10 | 31,955 |
| 34 | GH Guardant Health Inc Since 2026-05-10 | 40131M109 | Equity (Common) |
0.55%
|
$3.14 | 30,762 |
| 35 | HOLX Hologic Inc Since 2026-05-10 | 436440101 | Equity (Common) |
0.16%
|
$0.91 | 12,193 |
| 36 | HUM Humana Inc Since 2026-05-10 | 444859102 | Equity (Common) |
0.30%
|
$1.73 | 6,765 |
| 37 | IDXX IDEXX Laboratories Inc Since 2026-05-10 | 45168D104 | Equity (Common) |
0.80%
|
$4.54 | 6,712 |
| 38 | ILMN Illumina Inc Since 2026-05-10 | 452327109 | Equity (Common) |
0.31%
|
$1.74 | 13,293 |
| 39 | IMNM Immunome Inc Since 2026-05-10 | 45257U108 | Equity (Common) |
0.10%
|
$0.54 | 25,340 |
| 40 | ISRG Intuitive Surgical Inc Since 2026-05-10 | 46120E602 | Equity (Common) |
2.74%
|
$15.58 | 27,505 |
| 41 | IONS Ionis Pharmaceuticals Inc Since 2026-05-10 | 462222100 | Equity (Common) |
0.21%
|
$1.19 | 14,983 |
| 42 | IQV IQVIA Holdings Inc Since 2026-05-10 | 46266C105 | Equity (Common) |
0.35%
|
$1.99 | 8,817 |
| 43 | KALV KalVista Pharmaceuticals Inc Since 2026-05-10 | 483497103 | Equity (Common) |
0.05%
|
$0.30 | 18,705 |
| 44 | KOD Kodiak Sciences Inc Since 2026-05-10 | 50015M109 | Equity (Common) |
0.08%
|
$0.46 | 16,563 |
| 45 | KYMR Kymera Therapeutics Inc Since 2026-05-10 | 501575104 | Equity (Common) |
0.06%
|
$0.37 | 4,712 |
| 46 | LBRX LB Pharmaceuticals Inc Since 2026-05-10 | 50180M108 | Equity (Common) |
0.19%
|
$1.07 | 48,308 |
| 47 | MBX MBX Biosciences Inc Since 2026-05-10 | 55287L101 | Equity (Common) |
0.16%
|
$0.90 | 28,457 |
| 48 | MAZE Maze Therapeutics Inc Since 2026-05-10 | 578784100 | Equity (Common) |
0.12%
|
$0.66 | 15,965 |
| 49 | MRK Merck & Co Inc Since 2026-05-10 | 58933Y105 | Equity (Common) |
3.65%
|
$20.73 | 196,949 |
| 50 | MTD Mettler-Toledo International Inc Since 2026-05-10 | 592688105 | Equity (Common) |
0.10%
|
$0.55 | 395 |
| 51 | MRNA Moderna Inc Since 2026-05-10 | 60770K107 | Equity (Common) |
0.25%
|
$1.44 | 48,852 |
| 52 | NTRA Natera Inc Since 2026-05-10 | 632307104 | Equity (Common) |
0.48%
|
$2.71 | 11,821 |
| 53 | NBIX Neurocrine Biosciences Inc Since 2026-05-10 | 64125C109 | Equity (Common) |
0.17%
|
$0.96 | 6,793 |
| 54 | NVS Novartis AG Since 2026-05-10 | 66987V109 | Equity (Common) |
0.53%
|
$3.01 | 21,810 |
| 55 | NUVL Nuvalent Inc Since 2026-05-10 | 670703107 | Equity (Common) |
0.51%
|
$2.88 | 28,618 |
| 56 | NUVB Nuvation Bio Inc Since 2026-05-10 | 67080N119 | Derivative |
0.00%
|
$0.00 | 4,050 |
| 57 | OCUL Ocular Therapeutix Inc Since 2026-05-10 | 67576A100 | Equity (Common) |
0.05%
|
$0.28 | 22,645 |
| 58 | OLMA Olema Pharmaceuticals Inc Since 2026-05-10 | 68062P106 | Equity (Common) |
0.10%
|
$0.56 | 22,205 |
| 59 | OBIO Orchestra BioMed Holdings Inc Since 2026-05-10 | 68572M106 | Equity (Common) |
0.01%
|
$0.07 | 17,635 |
| 60 | ORKA Oruka Therapeutics Inc Since 2026-05-10 | 687604108 | Equity (Common) |
0.09%
|
$0.48 | 15,986 |
| 61 | PTCT PTC Therapeutics Inc Since 2026-05-10 | 69366J200 | Equity (Common) |
0.10%
|
$0.55 | 7,270 |
| 62 | PEN Penumbra Inc Since 2026-05-10 | 70975L107 | Equity (Common) |
0.63%
|
$3.61 | 11,606 |
| 63 | PFE Pfizer Inc Since 2026-05-10 | 717081103 | Equity (Common) |
0.45%
|
$2.58 | 103,734 |
| 64 | PTGX Protagonist Therapeutics Inc Since 2026-05-10 | 74366E102 | Equity (Common) |
0.49%
|
$2.80 | 32,058 |
| 65 | RDNT RadNet Inc Since 2026-05-10 | 750491102 | Equity (Common) |
0.12%
|
$0.68 | 9,485 |
| 66 | REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 | 75886F107 | Equity (Common) |
1.05%
|
$5.95 | 7,712 |
| 67 | RGNX REGENXBIO Inc Since 2026-05-10 | 75901B107 | Equity (Common) |
0.05%
|
$0.27 | 18,415 |
| 68 | RYTM Rhythm Pharmaceuticals Inc Since 2026-05-10 | 76243J105 | Equity (Common) |
0.88%
|
$5.01 | 46,799 |
| 69 | STOK Stoke Therapeutics Inc Since 2026-05-10 | 86150R107 | Equity (Common) |
0.23%
|
$1.30 | 41,095 |
| 70 | SMMT Summit Therapeutics Inc Since 2026-05-10 | 86627T108 | Equity (Common) |
0.25%
|
$1.40 | 80,150 |
| 71 | TERN Terns Pharmaceuticals Inc Since 2026-05-10 | 880881107 | Equity (Common) |
0.20%
|
$1.14 | 28,220 |
| 72 | TMO Thermo Fisher Scientific Inc Since 2026-05-10 | 883556102 | Equity (Common) |
2.76%
|
$15.68 | 27,058 |
| 73 | TCRX TScan Therapeutics Inc Since 2026-05-10 | 89854M101 | Equity (Common) |
0.01%
|
$0.05 | 48,273 |
| 74 | UPB Upstream Bio Inc Since 2026-05-10 | 91678A107 | Equity (Common) |
0.14%
|
$0.82 | 30,052 |
| 75 | PCVX Vaxcyte Inc Since 2026-05-10 | 92243G108 | Equity (Common) |
0.06%
|
$0.35 | 7,541 |
| 76 | VEEV Veeva Systems Inc Since 2026-05-10 | 922475108 | Equity (Common) |
0.34%
|
$1.94 | 8,702 |
| 77 | VIR Vir Biotechnology Inc Since 2026-05-10 | 92764N102 | Equity (Common) |
0.02%
|
$0.12 | 20,069 |
| 78 | VOR Vor BioPharma Inc Since 2026-05-10 | 929033207 | Equity (Common) |
0.02%
|
$0.13 | 10,020 |
| 79 | VYGR Voyager Therapeutics Inc Since 2026-05-10 | 92915B106 | Equity (Common) |
0.02%
|
$0.12 | 31,420 |
| 80 | WST West Pharmaceutical Services Inc Since 2026-05-10 | 955306105 | Equity (Common) |
0.48%
|
$2.73 | 9,928 |
| 81 | BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS INC Since 2026-05-10 | — | Equity (Common) |
0.03%
|
$0.20 | 15,582 |
| 82 | NYXH Nyxoah SA Since 2026-05-10 | — | Equity (Common) |
0.02%
|
$0.14 | 29,659 |
| 83 | BHVN Biohaven Ltd Since 2026-05-10 | — | Equity (Common) |
0.06%
|
$0.34 | 30,469 |
| 84 | MDT Medtronic PLC Since 2026-05-10 | — | Equity (Common) |
3.12%
|
$17.74 | 184,666 |
| 85 | ROIV Roivant Sciences Ltd Since 2026-05-10 | — | Equity (Common) |
0.16%
|
$0.89 | 41,221 |
| 86 | STE STERIS PLC Since 2026-05-10 | — | Equity (Common) |
0.26%
|
$1.49 | 5,880 |
| 87 | WVE WaVe Life Sciences Ltd Since 2026-05-10 | — | Equity (Common) |
0.09%
|
$0.51 | 30,090 |